Q4 2024 Surgery Partners Inc Earnings Call Transcript
Key Points
- Surgery Partners Inc (SGRY) reported a full year adjusted EBITDA growth of 16% and net revenue growth of 13.5%, marking the first time the company recorded revenue over $3 billion and adjusted EBITDA over $0.5 billion.
- The company experienced strong organic growth with same-facility revenue growth of 8%, driven by both case volume and rate improvements.
- Surgery Partners Inc (SGRY) added 14 surgical robots in 2024, enhancing their capability to perform complex and higher acuity procedures, particularly in orthopedics.
- The company successfully recruited over 750 new physicians in 2024, with a focus on orthopedic specialists, which is expected to significantly impact growth in 2025.
- Surgery Partners Inc (SGRY) opened eight de novo facilities in 2024 and has 12 more in the pipeline, indicating a strong commitment to expanding their operational footprint.
- The company incurred higher than typical transaction and integration costs in 2024 due to an increased number of acquisitions and de novo investments.
- Operating cash flows in 2024 were lower than originally estimated due to increased variable costs associated with acquisitions, incremental interest costs, and restructuring expenses.
- Surgery Partners Inc (SGRY) faces potential legislative risks related to site neutrality policies, although they estimate the worst-case scenario would impact only 1% of their net revenue.
- The company reported a change in the valuation allowance for deferred tax assets of $100 million, which could be misinterpreted as a negative financial indicator.
- Despite strong revenue growth, the company did not see significant operating leverage in the fourth quarter, with EBITDA in line with expectations despite a revenue beat.
Greetings. Welcome to Surgery Partners, Inc. Fourth Quarter 2024 Earnings Call. (Operator Instructions). As a reminder, this conference is being recorded.
It is now my pleasure to introduce Dave Doherty, CFO. Thank you. You may begin.
Good morning. During this call, we will make forward-looking statements. There are risk factors that could cause future results to be materially different from these statements that are described in this morning's press release and the reports we file with the SEC, each of which are available on our corporate website. The company does not undertake any duty to update these forward-looking statements.
In addition, we reference certain financial measures that are non-GAAP, which we believe can be useful in evaluating our performance. We reconciled these measures to the most applicable GAAP measure in this morning's press release.
With that, I will turn the call over to Eric Evans, our CEO. Eric?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
